To evaluate the outcomes of patients with incidentally detected asymptomatic calyceal stones on active surveillance, and to identify risk factors for stone-related adverse events (AEs).
Introduction
Urolithiasis is one of the most common diseases of the modern era. The prevalence varies greatly between geographic locations, ranging from 8% to 19% in males and 3% to 5% in females in Western countries [1, 2] . The number of upper urinary tract stone hospital episodes in the UK has increased by 63% to 83 050 from 2000 to 2010 [3] . The increasing prevalence of urolithiasis places a major economical and clinical burden on the healthcare system.
Due to an increase in renal imaging, a rise in incidentally detected calyceal stones has been seen in recent decades [4] . One study of 5 047 patients undergoing screening CT colonography found the screening prevalence of asymptomatic urolithiasis was 7.8%, with an average of 2.1 stones per patient [5] .
In current practice, treatment options for calyceal stones include active surveillance, ureterorenoscopy, extracorporeal shockwave lithotripsy (ESWL), or percutaneous nephrolithotomy (PCNL). There is little debate that symptomatic renal stones causing pain, obstruction, haematuria, renal failure, or infection, usually require treatment to remove the stone. Invasive treatments are also recommended for high-risk patients, such as patients with a solitary kidney, immunodeficiency, reconstructed urinary systems, high-risk occupations, poor treatment compliance, and children [6] .
Optimal management of low-risk patients is debatable and evidence on the management of asymptomatic calyceal stones is heterogeneous, making definitive recommendations difficult. Studies that have evaluated the natural history of asymptomatic calyceal stones have reported conflicting results with stone progression rates ranging from 32% to 77%, and spontaneous stone-passage rates between 12.5% and 29.1% [7] [8] [9] [10] [11] [12] [13] [14] .
The objective of the present study was to evaluate the outcomes of patients with incidentally detected asymptomatic calyceal stones and to identify risk factors for stone-related events.
Patients and Methods
In this retrospective case series, patients referred with asymptomatic calyceal stones to a single referral centre between August 2005 and August 2016 were included. The inclusion criteria for the study were all patients with nonobstructing calyceal stones diagnosed on CT, without stonerelated symptoms, normal baseline renal function, willingness to stay on active surveillance, and had attended at least one annual follow-up. Exclusion criteria were: stone-related symptoms, concurrent ureteric obstruction or renal pelvic stones, urinary tract abnormalities, solitary kidney, pregnancy, children, and patients who could not attend regular followup. All patients enrolling to active surveillance were counselled on stone-related events (pain, infection, obstruction, haematuria, and renal failure). This cohort included both patients with a new diagnosis of asymptomatic calyceal stones, as well as patients who were already on follow-up where data was collected only for the set study period. Overall 1 180 patients with calyceal stones were identified, out of which 238 patients (301 renal units) were eligible for the study (Fig. 1 ).
All patients were followed up annually in a dedicated stone clinic. All patients had non-contrast CT and plain radiography at the time of diagnosis. If the stone was radio-opaque then patients were followed with serial plain radiographs. The minority of patients with radiolucent stones (29 renal units) were followed by alternating annual ultrasonography and CT imaging. At each consultation a focussed history, examination, urine analysis, and review of imaging were conducted. Renal function biochemistry was reviewed annually.
Patients were evaluated for primary endpoints (spontaneous stone passage and need for stone-related surgical intervention, and secondary endpoints (stone-related symptoms and adverse events [AEs] ).
For the purpose of data analysis, each renal unit was analysed separately. The following variables were recorded on an Excel spread sheet; age, gender, new or recurrent stone former, single or multiple stones, stone location (upper, mid, lower, multiple locations), cumulative stone size (the sum of the largest diameter measurement of each stone) at diagnosis and study endpoint, stone growth dynamics, and whether the stone was radio-opaque or radiolucent.
A Cox proportional hazards model was used for primary endpoint analysis, and a frailty regression model adjusted shared variances for two renal units from the same patient in the event of asymptomatic bilateral calyceal stones. The cumulative risk of stone-related events was displayed using Kaplan-Meier curves.
Results

Patient Characteristics
The median (range) age of the patients was 56 (24-87) years. The mean (range) cumulative stone size per renal unit was 10.8 (3-63.8) mm. Most of the stones were found in the lower pole calyx only (43%). The remaining stones were distributed to upper pole calyx only (17%), mid-pole calyx only (23%), and multiple locations (18%). Demographics and stone characteristics are shown in Table 1 .
Continual Surveillance
At the end of the study, 177 (58.8%) renal units remained on active surveillance and of these 64% were male patients. The median (range) duration of follow-up was 63 (12-132) months.
There was a preponderance of renal units from patients aged >50 years (74%). Stones were more commonly located in the lower pole only (48%) as compared to the upper pole only (13%), and mid-pole only (20%), or multiple sites (19%). Most of the renal units in this group demonstrated no stone growth (73%), compared to only 5% with growth rates >1 mm annually (Fig. 2 ).
Spontaneous Stone Passage
In total, spontaneous stone passage occurred in 44 renal units (14.6%). The median (range) time from diagnosis to stone passage was 31 (2-85) months.
Patients aged <50 years were almost twice as likely to spontaneously pass their stone as older patients (P = 0.028).
The majority of the stones were small, with 84% having a cumulative stone size of <10 mm. This study demonstrated smaller stones (<10 mm) were significantly more likely to spontaneously pass than larger stones (both 10-19 and ≥20 mm stones, P = 0.037 and P = 0.031, respectively) ( Tables 2 and 3 , Fig. 2 ).
Renal units with stones demonstrating growth of >1 mm annually were significantly less likely to pass spontaneously compared to stones that had shown no growth (P = 0.014).
Patient's gender, stone location, number of stones, previous history of stones, laterality, had no statistical significance in terms of spontaneous stone-passage rates.
Stone-related Intervention
Stone-related intervention was required for 80 renal units (26.6%) during the study period. Of those that required intervention, the majority had ESWL (57.5%), followed by ureteroscopy (25%), PCNL (12.5%), and a minority of 5% required emergency renal decompression with either ureteric stenting or percutaneous nephrostomy. The most common rationale for active intervention was stone-related pain with no evidence of stone relocation (30%), followed by stone relocation into the ureter with or without pain (25%), sudden stone growth (16.3%), UTIs (12.5%), deteriorating renal function (10%), and patient's choice (6.3%). To conduct an accurate multivariate analysis of the variables affecting stone-related intervention in the study, we excluded renal units of patients who remained asymptomatic and proceeded to surgery entirely due to patient choice rather than an actual AE. Altogether five renal units were therefore excluded from statistical sub-analysis, as they did not represent a stone-related AE.
The median (range) time from diagnosis to need for intervention was 48 (2-120) months. In those in whom intervention was required, only 8% did so in the first 12 months.
Younger patients (aged <50 years) were significantly more likely to require intervention for their stone(s) than older patients (P = 0.018) ( Tables 2 and 3 ).
Stones that had grown by ≥1 mm annually over the surveillance period were significantly more likely to require intervention compared to stones that had shown no growth (P < 0.001).
Stone-related Symptoms
We evaluated any primary stone-related symptoms of the patients during the study period. Pain was determined to be due to urolithiasis on the basis of a typical renal colic history and clinical examination. Imaging with either plain radiograph or CT was performed to establish for stone relocation. UTI was determined to be due to urolithiasis on the basis of a positive urine culture (with typical stone-related organism) with investigative exclusion of other causes. Similarly, haematuria was only deemed to be secondary to urolithiasis after exclusion of other causes. Pain (n = 46, 15.3%) was the most common symptom, followed by infection/sepsis (n = 29, 9.6%), and haematuria (n = 16, 5.3%). Of the 46 renal units that were deemed to have stonerelated pain, 38 had surgical intervention, with the majority having symptom improvement after surgery (32 of 38 renal units). Of the 29 renal units that were deemed to have stonerelated infection, 10 had surgical intervention, with the majority having symptom improvement after surgery (seven of 10 renal units).
The median (range) time from diagnosis to first symptom was 43 (1-119) months in our study. Of those that had symptoms, only 9% had symptoms in the first 12 months, 40% between 12 and 36 months, 30% between 36 and 60 months, and 22% at >60 months.
Stones that had grown by ≥1 mm annually over the surveillance period were twice as likely to have stone-related symptoms compared to stones that had shown no growth z(P = 0.048) ( Tables 2 and 3) . There was a trend towards younger patients (aged <50 years) being more likely (1.7-times) to have stone-related symptoms compared to older patients (aged >50 years), but this was not statistically significant (P = 0.083).
Any Stone-related AE
We evaluated the outcomes of renal units that had any stonerelated AE (either symptoms and/or the need for stonerelated surgical intervention).
In all, 117 (39.5%) of the renal units had a stone-related AE. Not all patients that had a stone-related symptom chose to proceed with surgical intervention; therefore this sub-analysis demonstrated the most accurate predictor of stone-related AEs during surveillance in this study.
One of our patients died during the follow-up period secondary to an obstructed, infected renal unit leading to a stone-related mortality rate of nearly one in 300.
We found that patients aged <50 years had a significantly greater chance of developing a stone-related AE compared to older patients (P = 0.012; Tables 2 and 3 , Fig. 2 ).
Stones that had grown by ≥1 mm annually over the surveillance period were significantly more likely to develop a stone-related AE compared to stones that had shown no growth (P = 0.006).
Discussion
Our present study is one of the largest evaluating the natural history of asymptomatic calyceal stones with one of the longest follow-up periods. With a mean cumulative stone size of 10.8 mm, we studied 301 renal units with a mean followup of 63 months.
In one of the first retrospective studies on asymptomatic calyceal stones, H€ ubner et al. [7] analysed 62 patients over 88.8 months and found a similar spontaneous stone-passage rate of 16%. They also found similar progression rates (stone growth) of 45%. However, in contrast to our present series, the UTI rate was significantly higher at 68%, the surgical intervention rate was higher at 40%, and they concluded that 83% of all calyceal stones require intervention within 5 years of diagnosis [7] . In another retrospective study, Glowacki et al. [8] followed a cohort of 107 patients with asymptomatic stones for a mean period of 31.6 months. In all, 73 patients (68.2%) remained asymptomatic, 16 patients (15%) spontaneously passed their stone, and 18 patients (16.8%) required surgical intervention. They estimated the 5-year probability of a symptomatic stone-related event at 48.5%. Although this is a higher risk than in our present series (31.6%), the primary outcome figures are comparable. In contrast to our present study, they found a positive correlation between previous stones and number of stones to symptomatic stone-related events. However, these were not statistically significant [8] . It is important to note that the velocity of stone growth was not evaluated in the study.
With advancing technology, in the modern era, endourological procedures have become safer and more accessible. One would presume that contemporary literature on asymptomatic stones would show a trend towards a higher surgical intervention rate. However, in a study by Burgher et al. [10] , 300 patients with asymptomatic stones were followed-up for 39 months. They found the surgical intervention rate was 26%, which is the same as our present series more than a decade later. Burgher's group reported a disease progression (defined as stone growth, pain during follow-up, or need for surgical intervention) rate of 77% during follow-up. This disparity between disease progression and surgical intervention was not as pronounced in our present series, with a disease progression rate of 39.5% and a surgical intervention rate of 26.6%. This may be, in part, due to the fact that Burgher's cohort were older (62.8 years compared to 56 years) and were all males. In our present study, we found younger patients had a higher rate of stone-related surgical intervention, and females had a slighter higher rate of stone-related AEs, although this was not statistically significant.
Kang et al. [13] retrospectively followed 347 patients for 31 months. They reported a similar intervention rate of 24.5% and stone-related AE rate of 53.6% compared to our present series. They found younger patients are more likely to have a stone-related event; however, in contrast to our present study, they found males were more likely to have stone-related events. The spontaneous stone-passage rate was higher at 29.1% but their average stone size was considerably smaller than our present study at 4.4 mm. Consistent with our present series, they found that smaller stones, younger patients, and stones demonstrating no growth were more likely to have spontaneous stone passage.
In a recent study, Dropkin et al. [14] retrospectively followed a cohort of 160 stones from 110 patients for 41 months. There was a spontaneous stone-passage rate of 7%, symptom development rate of 28%, and a surgical intervention rate of <20%, which is comparable to our present series. Similar to our present study they found that sex, stone size, and stone multiplicity had no effect on stone-related symptoms. In contrast to our present series, they found that stones in the upper and mid-pole calyx were significantly more likely to pass spontaneously and to cause stone-related symptoms compared to lower pole stones. They also found stone growth had no effect on stone-related symptoms. However, their definition of stone growth was an increase in stone size of >50% compared to our present series where a change of 1 mm over time was measured. Therefore the data sets were not comparable. A summary of evidence on the natural history of asymptomatic calyceal stones is provided in Table 4 .
One of the limitations of our present study is the retrospective nature of data analysis. We had to exclude 33 patients from our present study due to failed attendance to clinic or because their follow-up period had been <12 months at the end of the study period. Analysis of renal units that were already on surveillance at the start of the study period was restricted to the study period dates (August 2005-August 2016) and not to the start date of surveillance. Although this allowed the study to capture all patients in the set time period, it introduced the potential to under-represent the efficacy of the surveillance group. Two independent clinicians performed stone-size measurements in both plain radiograph and CT imaging, and the mean of the difference was used for the analysis. Although this allowed a consistent result for radio-opaque stones, ultrasonography measurements were used intermittently with CT imaging in radiolucent stones, to avoid unnecessary radiation exposure, introducing the potential of some inaccuracies. However, only 29 renal units had radiolucent stones in our present study.
The present study has shown that surveillance of asymptomatic calyceal stones is safe. Overall, we found 15.3% of renal units complained of pain, 9.6% had a UTI, and 5.3% haematuria. Our infection rate was considerable lower than the H€ ubner et al. [7] study (9.6% vs 68%) but comparable to the more contemporary evidence. One patient died during follow-up secondary to pyonephrosis. She was 59-years-old with multiple comorbidities, including multiple sclerosis, who had a right lower pole 3-mm asymptomatic renal stone. After 2 years of surveillance she presented with profound sepsis and the stone had relocated to the right vesico-ureteric junction. She was promptly managed with a percutaneous nephrostomy. Due to her comorbidities she was not a candidate for intensive care treatment. She subsequently deteriorated and died despite full active ward-based treatment after completing a 'do not resuscitate' order. Although stone relocation to the ureter causing obstruction and infection has been described in the literature, previous studies have not described its incidence. Our present study has shown a disease-specific mortality of 0.33% in a follow-up period of 63 months.
The current evidence for the natural history of asymptomatic calyceal stones is heterogeneous and inconsistent. There is currently no consensus as to patient selection, interval between follow-up, and timing of surgical intervention. We present one of the largest series, with long-term follow-up evaluating the natural history of asymptomatic calyceal stones in our university hospital to aid decision-making and adequate counselling for this challenging increasing subset of patients. To date, no randomised prospective trial comparing active surveillance with surgical intervention for asymptomatic calyceal stones has been performed. 
Conclusions
Active surveillance is a viable alternative for the long-term management of asymptomatic calyceal stone disease. Our present series demonstrated a 14.6% probability of spontaneous stone passage, and 26.6% risk of requiring a surgical intervention during an average time of 63 months. Patients aged <50 years and stone growth >1 mm per year predicted the need for surgical intervention. Patients aged <50 years, with smaller stones, and no stone growth positively predicted the likelihood of spontaneous stone passage. The present study helps to highlight the importance of serial reviews with imaging to measure stone growth velocity, particularly in younger patients, and we hope that these findings will guide us in counselling patients who present with asymptomatic calyceal stones. It may also help guide clinicians in the safe discharge of older patients (aged >50 years) with no stone growth on serial imaging due to their reduced risk of stone-related AEs. Our present study is the first to provide an objective measure, while counselling patients with asymptomatic stones about the risk of stonerelated sepsis and mortality. Although the risk is very small, it may be relevant in vulnerable patients with other comorbidities and low cardio-pulmonary reserves.
